Related Experiment Video
Updated: Aug 2, 2026

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
Insulin receptor substrate proteins and diabetes
1Institute for Tumor Research, Chungbuk National University, Cheongju, Chungbuk 361-763, Korea.
Insulin receptor substrate (IRS) proteins link cell surface signals to intracellular cascades, crucial for insulin and IGF action. IRS2 signaling impacts insulin response and beta-cell function, with its dysregulation linked to insulin resistance and metabolic diseases.
Area of Science:
- Molecular biology
- Endocrinology
- Metabolic signaling
Background:
- Insulin receptor substrate (IRS) proteins are key mediators linking cell surface receptors to intracellular signaling pathways.
- IRS proteins coordinate signals from insulin, IGF receptor tyrosine kinases, proinflammatory cytokines, and nutrients.
- The IRS2 signaling pathway is critical for peripheral insulin response and pancreatic beta-cell growth and function.
Purpose of the Study:
- To elucidate the role of IRS proteins in insulin and IGF signaling.
- To understand the function of the IRS2-branch in metabolic regulation and disease.
- To explore IRS protein regulation and its implications for insulin resistance.
Main Methods:
- The study likely involved molecular biology techniques to investigate protein interactions and signaling pathways.
- Analysis of gene expression and protein levels related to IRS1 and IRS2.
- In vivo studies, potentially using mouse models, to assess the physiological impact of IRS2 dysregulation.
Main Results:
- IRS proteins are essential for relaying signals from insulin and IGF receptors.
- IRS2 signaling is vital for compensatory hyperinsulinemia in the face of peripheral insulin resistance.
- Downregulation of IRS protein signaling via serine phosphorylation or proteasomal degradation contributes to insulin resistance.
Conclusions:
- Understanding IRS1 and IRS2 regulation and signaling is crucial for metabolic health.
- Dysregulation of IRS2 signaling contributes to the pathophysiology of insulin resistance and metabolic diseases.
- Targeting IRS protein signaling may offer new therapeutic strategies for diabetes and other metabolic disorders.
More Related Videos
Related Concept Videos
Insulin Secretory Vesicles
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: The Receptor and Signaling Pathways
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Type I Diabetes II: Pathophysiology

